AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Therapies for COPD have been in development for decades to reduce exacerbations and manage the symptom load of the disease.
Therapies for COPD have been in development for decades to reduce exacerbations and manage the symptom load of the disease.